Dihydroergotamine mesylate is an active pharmaceutical ingredient used in the manufacturing of certain pharmaceutical products. According to state or federal government labeling requirements, it can cause developmental toxicity.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 6190-39-2
Acidihydroergocristine
pharmaceutical raw material
Dihydroergocristine mesylate
pharmaceutical raw material
Dihydro-α-ergocryptine mesylate
pharmaceutical raw material
Dimepranol acedoben
pharmaceutical raw material
Adrenalone hydrochloride
pharmaceutical raw material
Dopamine hydrochloride
pharmaceutical raw material
Sodium calcium edetate
pharmaceutical raw material
(6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide;methanesulfonic acid
ADYPXRFPBQGGAH-UMYZUSPBSA-N
C[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C.CS(=O)(=O)O